Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy (ARIES)

AstraZeneca

Status: Terminated

Conditions: Breast Cancer

Study type: Observational

Funder types: Industry

Identifiers

NCT00542594

NIS-OFR-ARI-2005/1

Details and patient eligibility

About

The purpose of this survey is to describe long-term tolerance as seen under current conditions of use for anastrozole.

Enrollment: 1,840 patients

Sex: Female

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• woman treated with anastrozole as adjuvant therapy for hormone-dependant breast cancer in post-menopausal women with positive hormone-receptors